Growth Metrics

Pacific Biosciences Of California (PACB) Non-cash Items (2016 - 2022)

Pacific Biosciences Of California has reported Non-cash Items over the past 10 years, most recently at $9.4 million for Q4 2022.

  • For Q4 2022, Non-cash Items fell 92.34% year-over-year to $9.4 million; the TTM value through Dec 2022 reached $9.4 million, down 92.34%, while the annual FY2022 figure was $9.4 million, 92.34% down from the prior year.
  • Non-cash Items for Q4 2022 was $9.4 million at Pacific Biosciences Of California, down from $122.9 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $298.8 million in Q4 2020 and troughed at $9.4 million in Q4 2022.
  • A 5-year average of $101.8 million and a median of $58.0 million in 2018 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: skyrocketed 3311.76% in 2018 and later crashed 92.34% in 2022.
  • Year by year, Non-cash Items stood at $58.0 million in 2018, then crashed by 65.52% to $20.0 million in 2019, then skyrocketed by 1394.0% to $298.8 million in 2020, then plummeted by 58.87% to $122.9 million in 2021, then crashed by 92.34% to $9.4 million in 2022.
  • Business Quant data shows Non-cash Items for PACB at $9.4 million in Q4 2022, $122.9 million in Q4 2021, and $298.8 million in Q4 2020.